Navigation Links
Lubiprostone in Medical News

New Guidelines Issued for Management of IBS

...n larger numbers of people is evaluated. Psychological counseling may also provide some relief. Selective C-2 chloride channel activators, notably lubiprostone (Amitiza), are effective for "constipation-predominant IBS." 5HT 3 antagonists such as alosetron (Lotronex) relieve symptoms of diarrhea but can c...

Drug brings relief for many IBS patients who experience constipation

...ogist William D. Chey, M.D., the studies show that lubiprostone significantly improves all of the symptoms associa...nvolving 1,154 participants. These trials compared lubiprostone versus a placebo during the course of 12 weeks. Ea...-C symptoms. After one week, 20 percent of the lubiprostone participants reported moderate to significant reli...

Silence Puts Comfort For Digestive Syndrome

...elabeled in 2004 to warn of a rare, serious side effect involving low blood pressure. IBS patients whose primary symptom is constipation, can take lubiprostone (Amitiza), which was approved in January for the treatment of chronic constipation in adults. Dr. Robert Sandler, vice president of the American s...

New compounds Help Sustain relief For Patients With Symptoms of Bowel Disorders

...Ranging, Double-Blind, Placebo-Controlled Study of lubiprostone in Subjects with Irritable Bowel Syndrome and Cons...tinal system. This study tested different doses of lubiprostone over 12 weeks in subjects with constipation-specif... four treatment groups: placebo or 16, 32 or 48 μg lubiprostone daily. Patients were asked to keep a log of their ...
Lubiprostone in Medical Technology

Sucampo Pharmaceuticals, Inc. Begins Pivotal Phase III Studies of Oral Lubiprostone to Treat Opioid-Induced Bowel Dysfunction (OBD)

First Patient Enrolled in Pivotal Studies BETHESDA, Md., Sept. 13 /PRNewswire-FirstCall/ -- Sucampo Pharmaceuticals, Inc. (Nasdaq: SCMP ) and Takeda Pharmaceuticals North America, Inc. today announced that the first patient has been enrolled in a Phase III study of lubiprostone...

New Study Demonstrates that Lubiprostone May Improve Symptom Relief Rates in Adults with Irritable Bowel Syndrome with Constipation (IBS-C)

WASHINGTON, May 21, 2007 /PRNewswire/ -- A new study demonstrated that the active ingredient in Amitiza (lubiprostone), given 8 mcg twice a day, may improve symptom relief rates in adults with irritable bowel syndrome with constipation (IBS-C). These results were presented as a late-breaker at Dig...

New Study Shows Probiotic Strain Effective in Improving Irritable Bowel Syndrome Symptoms

..., are FDA-approved only for certain types of IBS: alosetron is for women with severe IBS-related diarrhea only and has serious potential side effects; lubiprostone is only for women with IBS-related constipation. Doctors commonly recommend over-the-counter medications such as laxatives, antidiarrheals, and bulki...

New AMITIZA 8 mcg Phase III Studies Demonstrated Overall Symptom Improvement in Adult Women with Irritable Bowel Syndrome with Constipation (IBS-C)

... Oral; Sunday, May Improvement with lubiprostone in 18, 2008 at 3:00pm Patients ...d, Placebo- controlled Trials S1272 lubiprostone is Effective and Well Poster; Sunday, May ... presentation from Studies with lubiprostone 12pm-2pm PDT M1706 Discontinu...
Lubiprostone in Biological Technology

FDA Accepts Sucampo's sNDA for Lubiprostone (8 mcg) for the Treatment of Irritable Bowel Syndrome with Constipation (IBS-C)

Lower Strength of Approved Constipation Drug Offers Potential Treatment Option to Americans Suffering from IBS-C BETHESDA, Md., Sept. 17 /PRNewswire-FirstCall/ -- Sucampo Pharmaceuticals, Inc., (Nasdaq: SCMP ) today announced that the supplemental New Drug Application (sNDA) fo...

'Move to AMITIZA' Advertising Campaign Underscores the Power of Not Letting Chronic Constipation Slow People Down

...ce of such an obstruction prior to initiating AMITIZA treatment. The safety of AMITIZA in pregnancy has not been evaluated in humans. In guinea pigs, lubiprostone has been shown to have the potential to cause fetal loss. AMITIZA should be used during pregnancy only if the benefit justifies the potential risk to ...
Other Tags
(Date:12/19/2014)... Dec. 19, 2014 (HealthDay News) -- New research warns parents that ... lives at risk. Nearly half of teen drivers killed in ... were at least 11 years old and often lacked important safety ... Eighty-two percent of teen drivers killed in crashes were in cars ... to 10 years old, 31 percent were in cars 11 to ...
(Date:12/19/2014)... News) -- Injectable drug users who also use cocaine ... of other substance users, a new study finds. ... risk of suicide attempt and completed suicide," Didier Jutras-Aswad, ... in a university news release. "However, there are many ... who among substance users were actually more likely to ...
(Date:12/19/2014)... Raleigh, NC (PRWEB) December 19, 2014 Surviving ... asbestos and EPA information indicates that these pipes can leach ... to go to the full story on the Surviving ... to the erosion of natural asbestos deposits, decaying water mains ... in drinking water. , To protect consumers from ...
(Date:12/19/2014)... Kan. (PRWEB) December 19, 2014 B. ... exclusively to healthcare providers, has been retained to lead ... Johnson Memorial Hospital in Franklin, Ind. The top executive ... has recently placed more than 900 healthcare executives into ... county-owned, full service hospital providing care to the residents ...
(Date:12/19/2014)... Pain Free Living a leader in the ... new Superior magnetic necklace using ion neodymium ... neodymium magnets for the fastest pain relief in a ... Magnetics brand for the fastest relief by using 5200 ... using Superior Magnetic Jewelry at fairs and festivals” explained ...
Breaking Medicine News(10 mins):Health News:Older Cars a Bad Choice for Younger Drivers 2Health News:Cocaine, Amphetamines May Up Injection Drug Users' Suicide Risk 2Health News:Surviving Mesothelioma Warns of Potential Mesothelioma Risk from Cement Water Pipes 2Health News:Johnson Memorial Hospital Retains B. E. Smith to Recruit New Chief Financial Officer 2Health News:Johnson Memorial Hospital Retains B. E. Smith to Recruit New Chief Financial Officer 3Health News:New Superior Magnetic Necklace Relieves Migraine Headache 2
(Date:12/11/2014)... DUBLIN , Dec. 09, 2014 Research ... http://photos.prnewswire.com/prnh/20130307/600769 ( http://www.researchandmarkets.com/research/9ql3kr/biometrics_market ) ... Market in India 2015-2019" report to their ... in this market is the adoption of multimodal ... one characteristic of an individual for verification and ...
(Date:12/11/2014)... Minn. , Dec. 10, 2014  Data ... physiologic monitoring, has released a new series of ... of preclinical toxicology researchers. M series, part of ... toxicologists collect the best possible physiologic data when ... Adding functional endpoints to toxicology studies has ...
(Date:12/10/2014)... 2014  Valencell, a leader in performance biometric data ... demand from its licensees for highly accurate, clinically validated ... solely coming from fitness and health sectors, but first ... wearable is only as useful as the biometric data ... driver in long-term mass consumer adoption of wearable products," ...
Breaking Biology News(10 mins):Biometrics Market in India 2015-2019: Key Vendors are 3M Cogent, NEC, Safran and Suprema 2New telemetry implants expected to change how large animal toxicology studies are conducted 2Wearable Technology Products Demand Highly Accurate Biometric Technology 2
Other Contents